These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 924274)
41. [Taxonomic study on strain 1254 and its mutant 113]. Zhang Y; Li H; Lu W Wei Sheng Wu Xue Bao; 1993 Feb; 33(1):13-21. PubMed ID: 8503202 [TBL] [Abstract][Full Text] [Related]
42. Spontaneous variability of Streptomyces glomeratus, a producer of the amthracycline antibiotics beromycins. Blumauerová M; Podojil M; Gauze GF; Maksimova TS; Panos J; Vanĕk Z Folia Microbiol (Praha); 1980; 25(3):207-12. PubMed ID: 7399371 [TBL] [Abstract][Full Text] [Related]
43. [Increase in tylosin production by a commercial strain of Streptomyces fradiae]. Liutskanova DG; Stoilova-Disheva MM; Peltekova VT Prikl Biokhim Mikrobiol; 2005; 41(2):189-93. PubMed ID: 15859462 [TBL] [Abstract][Full Text] [Related]
44. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin. Räty K; Kunnari T; Hakala J; Mäntsälä P; Ylihonko K Mol Gen Genet; 2000 Sep; 264(1-2):164-72. PubMed ID: 11016846 [TBL] [Abstract][Full Text] [Related]
45. [Production of the antibiotic lienomycin in a culture of diastato chromogenes var. lienomycini]. Gauze GF; Maksimova TS; Ol'khovatova OL; Kudrina ES; Il'chenko GB Antibiotiki; 1971 May; 16(5):387-90. PubMed ID: 5002219 [No Abstract] [Full Text] [Related]
46. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides. Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928 [TBL] [Abstract][Full Text] [Related]
47. Biosynthesis of vineomycins A1 and B2. Imamura N; Kakinuma K; Ikekawa N; Tanaka H; Omura S J Antibiot (Tokyo); 1982 May; 35(5):602-8. PubMed ID: 7107524 [TBL] [Abstract][Full Text] [Related]
48. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities. Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366 [TBL] [Abstract][Full Text] [Related]
49. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730. Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395 [TBL] [Abstract][Full Text] [Related]
50. Clavulanic acid production by the MMS 150 mutant obtained from wild type Streptomyces clavuligerus ATCC 27064. da Silva Vasconcelos E; de Lima VA; Goto LS; Cruz-Hernández IL; Hokka CO Braz J Microbiol; 2013 Dec; 44(4):1049-57. PubMed ID: 24688492 [TBL] [Abstract][Full Text] [Related]
51. Biosynthesis of epsilon-rhodomycinone from glucose by Streptomyces C5 and comparison with intermediary metabolism of other polyketide-producing streptomycetes. Dekleva ML; Strohl WR Can J Microbiol; 1988 Nov; 34(11):1235-40. PubMed ID: 3208200 [TBL] [Abstract][Full Text] [Related]
52. [Characteristics of mutants of Streptomyces peucetius subsp. caesius ATCC 27952 resistant to anthracycline antibiotics]. Dubyts'ka LP; Fedorenko VO Mikrobiol Z; 2001; 63(4):53-61. PubMed ID: 11692678 [TBL] [Abstract][Full Text] [Related]
53. [Auxotrophic mutants in the selection of the rubomycin producer, Actinomyces coeruleorubidus]. Saburova TP; Lapchinskaia OA; Siniagina OP; Trutneva EM; L'vova NA Antibiotiki; 1977 Dec; 22(12):1095-100. PubMed ID: 596854 [TBL] [Abstract][Full Text] [Related]
54. Improved yields of daunomycinone glycosides in developmental mutants of Streptomyces coeruleorubidus. Blumauerová M; Pokorný V; Stastná J; Hostálek Z; Vanĕk Z Folia Microbiol (Praha); 1978; 23(4):249-54. PubMed ID: 689569 [TBL] [Abstract][Full Text] [Related]
55. Strain improvement by combined UV mutagenesis and ribosome engineering and subsequent fermentation optimization for enhanced 6'-deoxy-bleomycin Z production. Zhu X; Kong J; Yang H; Huang R; Huang Y; Yang D; Shen B; Duan Y Appl Microbiol Biotechnol; 2018 Feb; 102(4):1651-1661. PubMed ID: 29279956 [TBL] [Abstract][Full Text] [Related]
56. Isolation and characterization of 8-demethoxy steffimycins and generation of 2,8-demethoxy steffimycins in Streptomyces steffisburgensis by the nogalamycin biosynthesis genes. Kunnari T; Tuikkanen J; Hautala A; Hakala J; Ylihonko K; Mäntsälä P J Antibiot (Tokyo); 1997 Jun; 50(6):496-501. PubMed ID: 9268006 [TBL] [Abstract][Full Text] [Related]
57. Improvement of microbial strain and fermentation process of rapamycin biosynthesis. Baby Rani P; Battula SK; Rao AK; Gunja M; Narasu ML Prep Biochem Biotechnol; 2013; 43(6):539-50. PubMed ID: 23742086 [TBL] [Abstract][Full Text] [Related]
58. Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes: clarification of actinorhodin gene functions. Bartel PL; Zhu CB; Lampel JS; Dosch DC; Connors NC; Strohl WR; Beale JM; Floss HG J Bacteriol; 1990 Sep; 172(9):4816-26. PubMed ID: 2394677 [TBL] [Abstract][Full Text] [Related]
59. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization. Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846 [TBL] [Abstract][Full Text] [Related]
60. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Madduri K; Kennedy J; Rivola G; Inventi-Solari A; Filippini S; Zanuso G; Colombo AL; Gewain KM; Occi JL; MacNeil DJ; Hutchinson CR Nat Biotechnol; 1998 Jan; 16(1):69-74. PubMed ID: 9447597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]